Meyer Handelman Co. acquired a new stake in LHC Group, Inc. (NASDAQ:LHCG) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,836 shares of the health services provider’s stock, valued at approximately $266,000.

Several other institutional investors and hedge funds have also bought and sold shares of LHCG. State of Alaska Department of Revenue lifted its position in LHC Group by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 9,775 shares of the health services provider’s stock worth $917,000 after purchasing an additional 150 shares during the period. Eqis Capital Management Inc. lifted its position in LHC Group by 6.2% in the fourth quarter. Eqis Capital Management Inc. now owns 4,837 shares of the health services provider’s stock worth $454,000 after purchasing an additional 281 shares during the period. Private Capital Group LLC lifted its position in LHC Group by 60.2% in the fourth quarter. Private Capital Group LLC now owns 897 shares of the health services provider’s stock worth $84,000 after purchasing an additional 337 shares during the period. Great Lakes Advisors LLC lifted its position in LHC Group by 15.8% in the third quarter. Great Lakes Advisors LLC now owns 2,779 shares of the health services provider’s stock worth $286,000 after purchasing an additional 379 shares during the period. Finally, Financial Gravity Companies Inc. bought a new position in LHC Group in the fourth quarter worth $49,000. 90.50% of the stock is owned by institutional investors.

Shares of NASDAQ:LHCG traded up $0.04 during midday trading on Monday, reaching $106.91. The company’s stock had a trading volume of 200 shares, compared to its average volume of 253,211. LHC Group, Inc. has a fifty-two week low of $59.21 and a fifty-two week high of $112.22. The firm has a market cap of $3.35 billion, a PE ratio of 44.18, a price-to-earnings-growth ratio of 1.52 and a beta of 0.89. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.61 and a current ratio of 1.61.

Several research analysts recently commented on the company. Barclays assumed coverage on LHC Group in a research report on Friday, December 14th. They issued an “equal weight” rating and a $105.00 target price for the company. UBS Group assumed coverage on LHC Group in a research report on Thursday, November 15th. They issued a “buy” rating and a $109.00 target price for the company. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 7th. Robert W. Baird increased their price objective on LHC Group from $95.00 to $98.00 and gave the stock a “neutral” rating in a research note on Friday, November 2nd. Finally, Craig Hallum lowered LHC Group from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $99.00 to $92.00 in a research note on Friday, October 26th. Four analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $105.77.

In related news, SVP Jeff Reibel sold 5,239 shares of LHC Group stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $105.26, for a total value of $551,457.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $103.40, for a total value of $7,755,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 241,821 shares of company stock valued at $24,422,790. 6.80% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Meyer Handelman Co. Acquires New Stake in LHC Group, Inc. (LHCG)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2019/02/11/meyer-handelman-co-acquires-new-stake-in-lhc-group-inc-lhcg.html.

LHC Group Company Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

See Also: Fundamental Analysis and Choosing Stocks

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.